 Connection
Naresh Mandava to Fluorescein Angiography
This is a "connection" page, showing publications Naresh Mandava has written about Fluorescein Angiography.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.109 |
|
|
|
-
de Carlo Forest TE, Gill Z, Lisker-Cervantes A, Gnanaraj R, Grove N, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N. Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate. Am J Ophthalmol. 2024 08; 264:168-177.
Score: 0.779
-
Lopez J, de Carlo Forest TE, Azargui S, Gill ZS, Lisker-Cervantes A, Gnanaraj R, Lynch AM, Palestine AG, Mandava N, Mathias MT, Manoharan N, Grove N, Bradley C, Patnaik JL. Visual functioning and geographic atrophy imaging characteristics in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2026 Apr; 264(4):927-934.
Score: 0.220
-
Gnanaraj R, Lisker-Cervantes A, Patnaik J, Rajeswaren V, Mehta N, Gange W, Lynch AM, Palestine A, Mathias M, Manoharan N, Mandava N, Forest TEC. Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry. BMJ Open Ophthalmol. 2025 Apr 05; 10(1).
Score: 0.209
-
Lisker-Cervantes A, Gill Z, Gnanaraj R, Rajeswaren V, Mehta N, Gange B, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N, de Carlo Forest TE. Differences in imaging biomarkers between patients with intermediate and advanced non-neovascular age-related macular degeneration (AMD) in the University of Colorado AMD registry. Eur J Ophthalmol. 2025 Jan; 35(1):276-282.
Score: 0.196
-
Chen RC, Palestine AG, Lynch AM, Patnaik JL, Wagner BD, Mathias MT, Mandava N. Increased Systemic C-Reactive Protein Is Associated With Choroidal Thinning in Intermediate Age-Related Macular Degeneration. Transl Vis Sci Technol. 2021 10 04; 10(12):7.
Score: 0.164
-
Olson JL, Courtney RJ, Mandava N. Intravitreal infliximab and choroidal neovascularization in an animal model. Arch Ophthalmol. 2007 Sep; 125(9):1221-4.
Score: 0.062
-
Prall FR, Drack A, Taylor M, Ku L, Olson JL, Gregory D, Mestroni L, Mandava N. Ophthalmic manifestations of Danon disease. Ophthalmology. 2006 Jun; 113(6):1010-3.
Score: 0.057
-
Mandava N, Bartlett H, Young LH, Brooks HL. Diagnostic and therapeutic challenges. Retina. 2006 Feb; 26(2):214-8.
Score: 0.055
-
Olson JL, Mandava N. Macular hole formation associated with idiopathic parafoveal telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2006 Mar; 244(3):411-2.
Score: 0.054
-
Lisker-Cervantes A, Gill Z, Patnaik JL, Gnanaraj R, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N, de Carlo Forest TE. Association Between Systemic Levels of Vascular Endothelial Growth Factor and Optical Coherence Tomography Biomarkers in a Non-Neovascular Age-Related Macular Degeneration Cohort. Ophthalmic Surg Lasers Imaging Retina. 2025 Jan; 56(1):23-29.
Score: 0.050
-
Rajeswaren V, Wagner BD, Patnaik JL, Mandava N, Mathias MT, Manoharan N, De Carlo Forest TE, Gnanaraj R, Lynch AM, Palestine AG. Interleukin-4 Plasma Levels Stratified by Sex in Intermediate Age-Related Macular Degeneration and Geographic Atrophy. Transl Vis Sci Technol. 2023 08 01; 12(8):1.
Score: 0.047
-
Fonteh CN, Palestine AG, Wagner BD, Patnaik JL, Mathias MT, Manoharan N, Mandava N, Baldermann R, De Carlo T, Lynch AM. RANTES (CCL5) in Patients With Geographic Atrophy Age-Related Macular Degeneration. Transl Vis Sci Technol. 2023 01 03; 12(1):19.
Score: 0.045
-
Lynch AM, Mandava N, Patnaik JL, Frazer-Abel AA, Wagner BD, Palestine AG, Mathias MT, Siringo FS, Cathcart JN, Holers VM. Systemic activation of the complement system in patients with advanced age-related macular degeneration. Eur J Ophthalmol. 2020 Sep; 30(5):1061-1068.
Score: 0.035
-
Schwartz S, Harasawa M, Baldivieso V, Sabel AL, Mandava N, Quiroz-Mercado H. Nonmydriatic fundus camera for diabetic retinopathy screening in a safety net hospital: effectiveness, prevalence, and risk factors. Eur J Ophthalmol. 2015 Mar-Apr; 25(2):145-52.
Score: 0.025
-
Bhandari R, Dacey M, Schwartz S, Olson J, Quiroz-Mercado H, Mandava N, Oliver SC. Vogt-Koyanagi-Harada disease masquerading as a lymphoproliferative process of the uvea. Br J Ophthalmol. 2013 Nov; 97(11):1482-3, 1489-90.
Score: 0.023
-
Ernst BJ, García-Aguirre G, Oliver SC, Olson JL, Mandava N, Quiroz-Mercado H. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy. Acta Ophthalmol. 2012 Nov; 90(7):e573-4.
Score: 0.021
-
Pan CK, Durairaj C, Kompella UB, Agwu O, Oliver SC, Quiroz-Mercado H, Mandava N, Olson JL. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model. J Ocul Pharmacol Ther. 2011 Jun; 27(3):219-24.
Score: 0.020
-
Olson JL, Courtney RJ, Rouhani B, Mandava N, Dinarello CA. Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model. Ocul Immunol Inflamm. 2009 May-Jun; 17(3):195-200.
Score: 0.017
-
Gohel PS, Mandava N, Olson JL, Durairaj VD. Age-related macular degeneration: an update on treatment. Am J Med. 2008 Apr; 121(4):279-81.
Score: 0.016
-
Rudometkin N, Mandava N, Deane K, Olson JL. Infliximab in uveitis treatment. Arch Ophthalmol. 2006 Aug; 124(8):1211; author reply 1211-2.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|